What is Anhui Huaheng Biotechnology Co., Ltd.'s (688639.SS) StockRank?

MoatMap's StockRank for Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) is 17/100, with a Strong Sell signal. This is a composite score combining Quality (39), Value (33), and Momentum (33) factor ranks across MoatMap's 19,000+ stock universe.

Does Anhui Huaheng Biotechnology Co., Ltd. have an economic moat?

Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Anhui Huaheng Biotechnology Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) is Strong Sell, based on a StockRank of 17/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Anhui Huaheng Biotechnology Co., Ltd. in?

Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688639.SS

STRONG SELLREMOVE

Anhui Huaheng Biotechnology Co., Ltd. · Healthcare · China · $868M · Avg Vol: $16M/d

StockRank

P/E (TTM)

42.6x

ROE

4.3%

D/E

0.9x

Dividend %

0.8%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

A synthetic biology company producing amino acids. While it has an interesting technology platform, the market is highly competitive, and the current valuation does not offer a margin of safety given the strong sell quant signal.

COMPANY DESCRIPTION

Anhui Huaheng Biotechnology Co., Ltd. is a global leader in the industrial production of bio-based amino acids, particularly L-alanine and L-valine, utilizing advanced microbial fermentation technologies. The company's products serve as essential ingredients in animal feed, food additives, and personal care products. Its competitive moat is defined by proprietary metabolic engineering technologies, highly efficient continuous fermentation processes, and a significant cost advantage over traditional chemical synthesis methods.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	210M	286M	322M	423M	26.4%
EPS	0.21	0.29	0.12	0.08	-27.8%
Shares	228M	228M	250M	250M	+9.7%
Debt	12M	184M	228M	304M	196.2%
Equity	219M	270M	379M	391M	21.4%
Op CF	53M	45M	30M	15M	-33.6%
Inv CF	-51M	-167M	-137M	-95M	—
Fin CF	954,742	151M	115M	60M	—

PRICE (1M)-23.5%

SMA 50SMA 200

$3.15

RSI (14)

19.5

52W High

$6.41

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

3.8%53.3

ROE

4.3%54.3

GP/Assets

10.2%26.1

Op. Margin

7.6%60.7

FCF/Assets

-10.8%27.1

Piotroski

—55.8

Int. Cover

3.9x51.1

D/E Ratio

0.89x17.1

Current Ratio

1.21x15.8

Value

P/E (TTM)

42.6x24.7

EV/EBITDA

18.4x21.3

P/FCF

—N/A

P/B

2.0x56.1

P/S

1.8x70.7

Div Yield

0.8%20.6

Momentum

52W High %

49%22.4

RS 6M

-40%29.0

SMA 50/200

0.80x12.8

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+196%87.1

Q Growth

-18%26.5

FUNDAMENTALS

Market Cap

$868M

P/E (Forward)

14.4x

Gross Margin

19.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688639.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688639.SS	Anhui Huaheng Biotechnology Co., Ltd.(you)	$868M	17	STRONG SELL
2256.HK	Abbisko Cayman Limited	$826M	18	STRONG SELL
688197.SS	Shouyao Holdings (Beijing) Co., LTD.	$804M	19	STRONG SELL
2157.HK	Lepu Biopharma Co., Ltd.	$981M	15	STRONG SELL
2105.HK	Laekna, Inc.	$666M	15	STRONG SELL
300294.SZ	China Resources Boya Bio-pharmaceutical Group Co.,Ltd	$1.2B	16	STRONG SELL
300149.SZ	ChemPartner PharmaTech Co.,Ltd.	$642M	15	STRONG SELL
688302.SS	Hinova Pharmaceuticals Inc.	$582M	14	STRONG SELL
2659.HK	Shanghai Bao Pharmaceuticals Co., Ltd.	$1.0B	10	STRONG SELL
688068.SS	Beijing Hotgen Biotech Co., Ltd.	$1.2B	12	STRONG SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) — Stock Score Summary

Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) has a MoatMap StockRank of 17/100 based on Quality (39/100), Value (33/100), and Momentum (33/100) factor scores. The current signal is STRONG SELL. A synthetic biology company producing amino acids. While it has an interesting technology platform, the market is highly competitive, and the current valuation does not offer a margin of safety given the strong sell quant signal.

Key Financial Metrics

Price	$3.15
Market Cap	$868M
P/E (TTM)	42.60
P/E (Forward)	14.39
Price/Book	1.96
Return on Equity	4.3%
Return on Invested Capital	3.8%
Debt/Equity	88.70
Gross Margin	19.9%
Operating Margin	7.6%
Revenue Growth	12.3%
Dividend Yield	0.8%
Free Cash Flow	$-14M

Anhui Huaheng Biotechnology Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Anhui Huaheng Biotechnology Co., Ltd.’s (688639.SS) StockRank?: MoatMap’s StockRank for Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) is 17/100, with a Strong Sell signal. It is a composite of Quality (39), Value (33), and Momentum (33) factor ranks across MoatMap’s 19,000+ stock universe.
Does Anhui Huaheng Biotechnology Co., Ltd. have an economic moat?: Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Anhui Huaheng Biotechnology Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) is Strong Sell, based on a StockRank of 17/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Anhui Huaheng Biotechnology Co., Ltd. in?: Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).